VIR
Vir Biotechnology, Inc. Common Stock
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Best Biotech Stocks 2026 →
Vir Biotechnology (VIR) Stock: Buy, Sell, or Hold?
$13.13
-0.02 (-0.15%)
▼
5d:
+11.55%
30d:
+23.75%
90d:
+45.89%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
37/100
Position
EXTENDED
30-Day Fair Range
$10.46 – $12.23
Position: EXTENDED
Forward P/E & Valuation
-5.6x
Next 12M consensus est.
Wall Street Target
$22.50
+71.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$10.98 / $14.38
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: VIR shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When VIR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: VIR is currently trading at $13.13, which is considered extended relative to its 30-day fair value range of $10.46 to $12.23.
Technical Outlook: Technically, VIR is in a uptrend. Immediate support is located at $10.98, while resistance sits at $14.38.
Market Sentiment: VIR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $22.50 (+71.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VIR is in a uptrend. Immediate support is located at $10.98, while resistance sits at $14.38.
Market Sentiment: VIR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $22.50 (+71.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$10.46 -
$12.23
Company Quality Score
37/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$10.46 -
$12.23
Current vs Trading Range
EXTENDED
Support Level
$10.98
Resistance Level
$14.38
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range (+7.4% above its trading range)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 71.4% below Wall St target ($22.50)
- WARNING: Composite score 37/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-5.59
Wall Street Target
$22.50
(+71.4%)
Revenue Growth (YoY)
19582.5%
Earnings Growth (YoY)
58.5%
Profit Margin
-61.0%
Share VIR Analysis
Share this live VIR analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (VIR)
Bullish
3 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Nov 9, 2026
Daily AI digest
AI Retail Discussion Summary:
VIR stock surged after the company announced compelling evidence of best-in-class efficacy in the Phase 3 ECLIPSE-1 trial for Elebsiran and Tobevibart in Chronic Hepatitis Delta. All patients in the Solstice study achieved undetectable virus levels after 96 weeks.
Key Retail Themes:
Positive clinical trial results
Buyout buzz
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:00 PM ET
Data refreshes hourly during market hours. Next update: 9:00 PM
Data refreshes hourly during market hours. Next update: 9:00 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VIR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 35 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 38 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 31 SELL |
|
NAMS
NewAmsterdam Pharma Comp… |
STRONG BUY
16 analysts |
$50 | 44 HOLD |
|
IMUX
Immunic Inc |
STRONG BUY
13 analysts |
$43 | 51 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive VIR Research Pages
